Fukudo S, Endo Y, Hongo M et al. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomized, placebo-controlled, double-blind phase 2 trial. Lancet Gastroenterol Hepatol 2018;3:603–613.